Programa Nacional de Hepatites Virais - Brazil (National program)

Programa Nacional de Hepatites Virais - Brazil (National program)

Virus
Hepatitis B
Hepatitis C
Type
Testing and treatment implementation
Setting
National
Other targets
HAV
Hepatitis D virus
Hepatitis E
Phase
Active
Health outcomes
Incidence
Mortality
Prevalence
WHO region
Region of the Americas
Target goal
Country
Brazil
Key interventions
Blood safety
Community mobilization
Injection safety and infection control
Prevention mother-child transmission
Strategic data analysis
Testing and diagnosis
Treatment (direct or referral)
Target population
Birth cohorts of adults
Blood transfusion recipients
Household contact(s)
Incarcerated populations (current and former)
Infants (less than one year of age)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Sexual contact(s)
Performance target
Care cascade: HCV treatment
HBV prevention of mother to child transmission
Injection safety
Vaccination coverage
If you would like to have a program page for your program, please create an account and submit program information here

Performance target additional info

Hemodialisis patients and drugs users (non-injection drug use) also targeted.

Summary and objectives

The main objective is elimination of hepatitis C.

Greatest challenge is screening and diagnosis.

This program started in  2009, but since 2015, 115,940 persons have been treated with DAAs.

Last updated